Archive
Materials Available from FDA Basics Webinar on “Indoor Tanning: Risks of UV Radiation”
Did you miss the FDA Basics webinar on “FDA’s Regulation of Tobacco Products”?
Check out the “What’s New” box on the FDA Basics home page to download materials from the webinar. We have posted a link to listen to the entire 30 minute webinar as well posted a link to download a copy of the presentation slides.
You can find materials from past FDA Basics webinars here.
Afia Asamoah
Transparency Initiative Coordinator
Like this:
Materials Available from FDA Basics Webinar on “Safeguarding the U.S. Food Supply, Excellent Industry Compliance with the Final Bovine Spongiform Encephalopathy (BSE) Rule”
Did you miss the FDA Basics webinar on Safeguarding the U.S. Food Supply, Excellent Industry Compliance with the Final Bovine Spongiform Encephalopathy (BSE) Rule?
Check out the "What's New" box on the FDA Basics home page to download materials from the webinar.
There, you will find a link to listen to the entire 30 minute webinar and you can download a copy of the presentation slides.
Afia Asamoah, Transparency Initiaitve Coordinator
Like this:
Upcoming Events: FDA Basics Webinar on Indoor Tanning: Risks of UV Radiation, Wednesday, May 26, 2 p.m. ET
Do you have questions about Indoor Tanning? Did you know that FDA regulates tanning beds?
As part of FDA Basics, FDA is hosting a webinar where you can learn more. Featured speakers, Sharon Miller, M.S.E.E., FDA Ultraviolet Radiation Expert and Varsha Savalia, M.P.H, FDA Tanning Products Compliance Officer from the Division of Mammography Quality and Radiation Programs, Center for Devices and Radiological Health, will explain what UV radiation is, discuss the risks of UV radiation, and describe steps to reduce the risks associated with the use of tanning beds. After the presentation, there will be an opportunity to ask questions.
The free 30 minute webinar will be held on Wednesday, May 26, at 2 p.m. ET.
There are a limited number of spots available for the webinar. Materials from the webinar will also be made available on the FDA Web site. Click here for more information, including instructions about how to join the webinar.
Afia Asamoah
Transparency Initiative Coordinator
Like this:
FDA Unveils Draft Proposals on Agency Disclosure Policies for Public Comment
Today, as part of the second phase of the Transparency Initiative, the Transparency Task Force released 21 draft proposals about FDA’s disclosure policies. FDA is asking for comments on the proposals for 60 days. After 60 days, FDA will use your input to recommend specific proposals to FDA Commissioner Dr. Margaret Hamburg for implementation.
You can read more about the transparency report FDA is releasing today in a Perspective article in the New England Journal of Medicine online, “Transparency at the U.S. Food and Drug Administration.”
FDA will not necessarily implement each of these ideas. Some of the proposals require extensive resources to implement and some may require changes to regulations or legislation.
You can learn about the various ways to give us feedback here.
Visit the FDA Web site to read the report and comment on the proposals. You can let us know what you think about the proposals and what proposals FDA should prioritize, until July 20, 2010.
Afia Asamoah, Transparency Initiative Coordinator
